ATG101

Across TCGA pan-cancer cohorts, ATG101 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of ATG101’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where ATG101 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ATG101 is over-expressed in tumor.

COAD, HNSC, and LIHC are the cancer types where ATG101 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ATG101 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	+1.056	<.001	11	view →
HNSC	Male	IV	+1.049	<.001	10	view →
LIHC	All	II,III,IV	+0.603	<.001	7	view →
BRCA	All	All	+0.404	<.001	6	view →
STAD	All	II,III,IV	+0.681	<.001	4	view →
LUSC	Male	All	+0.512	<.001	4	view →
ESCA	All	All	+0.642	<.001	3	view →
READ	All	All	+0.448	.003	3	view →
CHOL	Male	All	+2.034	<.001	2	view →
LUAD	All	IV	+0.699	.002	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

ATG101–COAD

Open the COAD breakdown →